Loading clinical trials...
Loading clinical trials...
A Phase I Dose Escalation Trial of Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of the Head and Neck
Conditions
Interventions
Cisplatin
Stereotactic Body Radiation Therapy (SBRT)
Locations
1
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Start Date
July 16, 2014
Primary Completion Date
August 24, 2021
Completion Date
August 24, 2021
Last Updated
January 19, 2023
NCT05075980
NCT05815927
NCT06736379
NCT05329532
NCT05059444
NCT06823479
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions